Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease

Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation a...

Full description

Saved in:

Bibliographic Details
Published in:	Renal failure Vol. 40; no. 1; pp. 534 - 540
Main Authors:	Sangeetha Lakshmi, B., Harini Devi, N., Suchitra, M. M., Srinivasa Rao, P. V. L. N., Siva Kumar, V.
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis 01-11-2018 Taylor & Francis Ltd Taylor & Francis Group
Subjects:	Adult Aged Biomarkers - blood C-Reactive Protein - analysis Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - etiology Case-Control Studies Clinical Study End-stage renal disease Female Hemodialysis Humans Immune response India inflammation Inflammation - blood Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Malondialdehyde - blood Middle Aged Morbidity Oxidative Stress oxidative stress; Pentraxin-3 Pentraxins Population studies Renal Dialysis - adverse effects Risk Factors Serum Amyloid P-Component - analysis hemodialysis Cardiovascular disease inflammation oxidative stress; Pentraxin-3
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease. Methods: Twenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group. Results: This study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls. Conclusions: Hemodialysis procedure contributes to inflammation and oxidative stress.
AbstractList	Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease. Methods: Twenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group. Results: This study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls. Conclusions: Hemodialysis procedure contributes to inflammation and oxidative stress. Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease. Twenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group. This study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls. Hemodialysis procedure contributes to inflammation and oxidative stress. Background : Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5–20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease. Methods: Twenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group. Results: This study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls. Conclusions: Hemodialysis procedure contributes to inflammation and oxidative stress. Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5–20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease. Methods: Twenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group. Results: This study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls. Conclusions: Hemodialysis procedure contributes to inflammation and oxidative stress. BACKGROUNDCardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20 times higher than in the general population. Some of the nontraditional risk factors such as oxidative stress and inflammation are related to the progress of CVD in HD patients. Several, but not all studies, reported that inflammatory and oxidative stress markers are increased during a single session of HD, mimicking changes that occur during acute immune activation. This study was taken up to evaluate the changes in the inflammatory and oxidative stress markers during a single HD session in patients with chronic kidney disease.METHODSTwenty-five ESRD patients on maintenance HD and 25 controls were included in the study. Blood samples were obtained from the patients before starting of hemodialysis (pre-HD) and after completion of hemodialysis (post-HD). The changes in serum Pentraxin-3, hs-CRP, malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) levels were measured in pre- and post-HD ESRD patients and compared with healthy control group.RESULTSThis study found increased levels of Pentraxin-3, hs-CRP, MDA, and decreased level of FRAP in HD patients compared to controls.CONCLUSIONSHemodialysis procedure contributes to inflammation and oxidative stress.
Author	Harini Devi, N. Suchitra, M. M. Siva Kumar, V. Srinivasa Rao, P. V. L. N. Sangeetha Lakshmi, B.
Author_xml	– sequence: 1 givenname: B. surname: Sangeetha Lakshmi fullname: Sangeetha Lakshmi, B. organization: Department of Nephrology, Sri Venkateswara Institute of Medical Sciences – sequence: 2 givenname: N. surname: Harini Devi fullname: Harini Devi, N. organization: Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences – sequence: 3 givenname: M. M. surname: Suchitra fullname: Suchitra, M. M. organization: Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences – sequence: 4 givenname: P. V. L. N. surname: Srinivasa Rao fullname: Srinivasa Rao, P. V. L. N. email: seenupvln@yahoo.com organization: Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences – sequence: 5 givenname: V. surname: Siva Kumar fullname: Siva Kumar, V. organization: Department of Nephrology, Sri Venkateswara Institute of Medical Sciences
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30277113$$D View this record in MEDLINE/PubMed
BookMark	eNp9ks9u1DAQxiNURLeFRwBZ4sJlFzuxY-eCQBV_KlXiAhI3a2JPNt4m9mJnW_YBeG-c7raiHDiNZP_mm_lG31lx4oPHonjJ6IpRRd9SpWpalj9WJWVqxbiSSsgnxYKJUixrypuTYjEzyxk6Lc5S2lDKhJLls-K0oqWUjFWL4vdFD36NiThPph5z6QYYR5hC3BPwloRfzsLkbpCkKWJKZIR4jTERu4vOrwmQlMuApMcxWAfDPrlEUiZd8LPqNnejnxK5dVNPTB-Dd4ZcO-txT6xLCAmfF087GBK-ONbz4vunj98uviyvvn6-vPhwtTSiLqclMs6F6gwIirVk1kAjRfZi2hIraIGLGoRsregMB7AMaoldCVWngFWU0-q8uDzo2gAbvY0um9nrAE7fPYS41hAnZwbUVpkKKkXrFhredl1rTEdFyxVy1UCjsta7g9Z2145oTfYYYXgk-vjHu16vw42umWRcyCzw5igQw88dpkmPLhkcBvAYdkmXjAkpOKXzrNf_oJuwiz6fSleMNpSzSlWZEgfKxJBSxO5hGUb1HBp9Hxo9h0YfQ5P7Xv3t5KHrPiUZeH8AcjpCHOE2xMHqCfZDiF0Eb9zdHv-b8QexJddU
CitedBy_id	crossref_primary_10_1097_MD_0000000000036805 crossref_primary_10_1007_s11033_020_05712_z crossref_primary_10_3390_diagnostics13203216 crossref_primary_10_1111_jfbc_13534 crossref_primary_10_3390_antiox9111079 crossref_primary_10_1016_j_microb_2024_100050 crossref_primary_10_18410_jebmh_2020_596 crossref_primary_10_3390_medicina59091517 crossref_primary_10_1016_j_clnesp_2021_06_006 crossref_primary_10_1016_j_nut_2021_111205 crossref_primary_10_3390_antiox11061198 crossref_primary_10_1177_15593258221127568 crossref_primary_10_3390_diagnostics9040202 crossref_primary_10_2217_bmm_2021_0177 crossref_primary_10_1016_j_jad_2023_11_078 crossref_primary_10_1093_ckj_sfaa115 crossref_primary_10_3390_medsci7010004 crossref_primary_10_3390_antiox10071155 crossref_primary_10_32322_jhsm_1218704 crossref_primary_10_17352_jfsnt_000024 crossref_primary_10_3390_antiox8090409
Cites_doi	10.1093/ndt/14.suppl_1.76 10.1093/ndt/15.7.953 10.1016/S0140-6736(87)90266-2 10.1053/ajkd.1998.v32.pm9820470 10.1093/ndt/gfq273 10.1681/ASN.V1071606 10.4103/0971-4065.98758 10.1016/0003-2697(79)90738-3 10.1093/clinchem/18.6.499 10.1093/ndt/17.suppl_8.33 10.1046/j.1523-1755.1999.00613.x 10.1681/ASN.V13suppl_1s28 10.1515/CCLM.2002.019 10.2215/CJN.00870207 10.1016/j.tcm.2010.03.005 10.1053/j.ajkd.2009.06.022 10.1006/abio.1996.0292 10.2215/CJN.03670807 10.1161/01.CIR.102.6.636 10.1093/ndt/gfl747 10.1074/jbc.272.52.32817 10.5812/ircmj.22045 10.1097/01.ASN.0000143744.72664.66 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6
ContentType	Journal Article
Copyright	2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Copyright_xml	– notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 – notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
DBID	0YH CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7T5 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH H94 M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA
DOI	10.1080/0886022X.2018.1487857
DatabaseName	Taylor & Francis (Open access) Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts Research Library Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library Immunology Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
DocumentTitleAlternate	B. Sangeetha Lakshmi et al
EISSN	1525-6049
EndPage	540
ExternalDocumentID	oai_doaj_org_article_d8c3a3806ba94bffbccf05b48e489a98 10_1080_0886022X_2018_1487857 30277113 1487857
Genre	Clinical Study Journal Article
GrantInformation_xml	– fundername: Sri Balaji Arogya Varaprasadini Scheme of Sri Venkateswara Institute of Medical Sciences (SVIMS) – fundername: Tirumala Tirupati Devasthanams (TTD), Tirupati, A.P – fundername: ;
GroupedDBID	--- 00X 0R~ 0YH 123 29P 36B 4.4 53G 5RE AAPXX ABDBF ABPTK ACGEJ ACGFS ADBBV ADCVX ADRBQ ADXPE AENEX AEYQI AFKVX AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS AOIJS ARJSQ BABNJ BCNDV BENPR BLEHA CS3 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ H13 HYE HZ~ M4Z O9- OK1 P2P PQEST PQUKI PROAC RPM SV3 TFDNU TFL TFW TUS V1S ~1N .GJ 5VS 8G5 AALIY AAORF ABUWG ABWCV AFKRA AFLEI AJVHN AWYRJ AZQEC BPHCQ BRMBE CAG CCPQU CGR COF CUY CVF CYYVM CZDIS DRXRE DWQXO DWTOO ECM EIF GNUQQ GUQSH JENTW M2O M44 NPM NUSFT PIMPY PQQKQ QQXMO TDBHL ZGI ZXP AAYXX CITATION 3V. 7T5 7XB 8FK H94 MBDVC PRINS Q9U 7X8 5PM
ID	FETCH-LOGICAL-c562t-e14458fca50e671dca975302cb2e3aba456a57bd5fc4aad1a67ef2a3f8a130403
IEDL.DBID	RPM
ISSN	0886-022X
IngestDate	Tue Oct 22 15:14:33 EDT 2024 Tue Sep 17 21:13:04 EDT 2024 Fri Oct 25 10:28:02 EDT 2024 Thu Oct 10 21:15:11 EDT 2024 Fri Nov 22 01:49:41 EST 2024 Sat Sep 28 08:36:27 EDT 2024 Tue Jun 13 19:20:04 EDT 2023
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	hemodialysis Cardiovascular disease inflammation oxidative stress; Pentraxin-3
Language	English
License	open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c562t-e14458fca50e671dca975302cb2e3aba456a57bd5fc4aad1a67ef2a3f8a130403
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171457/
PMID	30277113
PQID	3109041383
PQPubID	3933335
PageCount	7
ParticipantIDs	doaj_primary_oai_doaj_org_article_d8c3a3806ba94bffbccf05b48e489a98 pubmed_primary_30277113 informaworld_taylorfrancis_310_1080_0886022X_2018_1487857 proquest_miscellaneous_2115754008 crossref_primary_10_1080_0886022X_2018_1487857 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171457 proquest_journals_3109041383
PublicationCentury	2000
PublicationDate	2018-Nov
PublicationDateYYYYMMDD	2018-11-01
PublicationDate_xml	– month: 11 year: 2018 text: 2018-Nov
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: New York
PublicationTitle	Renal failure
PublicationTitleAlternate	Ren Fail
PublicationYear	2018
Publisher	Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group
Publisher_xml	– name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group
References	19733948 - Am J Kidney Dis. 2009 Dec;54(6):1072-80 15504945 - J Am Soc Nephrol. 2004 Nov;15(11):2916-22 8660627 - Anal Biochem. 1996 Jul 15;239(1):70-6 10048460 - Nephrol Dial Transplant. 1999;14 Suppl 1:76-8 9820470 - Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9 36810 - Anal Biochem. 1979 Jun;95(2):351-8 10862630 - Nephrol Dial Transplant. 2000 Jul;15(7):953-60 17786277 - Int J Mol Med. 2007 Oct;20(4):471-81 10405218 - J Am Soc Nephrol. 1999 Jul;10(7):1606-15 17496115 - Nephrol Dial Transplant. 2007 Aug;22(8):2224-9 4337382 - Clin Chem. 1972 Jun;18(6):499-502 23087556 - Indian J Nephrol. 2012 May;22(3):200-5 10931803 - Circulation. 2000 Aug 8;102(6):636-41 11762945 - Arthritis Rheum. 2001 Dec;44(12):2841-50 9407058 - J Biol Chem. 1997 Dec 26;272(52):32817-23 25763223 - Iran Red Crescent Med J. 2014 Nov 11;16(11):e22045 11792759 - J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36 10469377 - Kidney Int. 1999 Sep;56(3):1078-83 2881162 - Lancet. 1987 Mar 14;1(8533):628-9 19967657 - J Nephrol. 2009 Nov-Dec;22(6):774-82 12147775 - Nephrol Dial Transplant. 2002;17 Suppl 8:33-8; discussion 40 20656213 - Trends Cardiovasc Med. 2010 Feb;20(2):35-40 17702732 - Clin J Am Soc Nephrol. 2007 Sep;2(5):889-97 11939481 - Clin Chem Lab Med. 2002 Feb;40(2):104-10 18184879 - Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21 20484301 - Nephrol Dial Transplant. 2010 Nov;25(11):3717-23 e_1_3_2_27_1 e_1_3_2_29_1 e_1_3_2_20_1 e_1_3_2_21_1 e_1_3_2_22_1 Matsubara K (e_1_3_2_24_1) 2009; 22 e_1_3_2_25_1 Hacişevki A (e_1_3_2_26_1) 2008; 37 Reddy PE (e_1_3_2_30_1) 2011; 2 e_1_3_2_16_1 e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_8_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_31_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_13_1 e_1_3_2_4_1 e_1_3_2_14_1 e_1_3_2_3_1 e_1_3_2_15_1 Reddy PE (e_1_3_2_28_1) 2010; 2 Malaponte G (e_1_3_2_23_1) 2007; 20
References_xml	– ident: e_1_3_2_14_1 doi: 10.1093/ndt/14.suppl_1.76 – ident: e_1_3_2_11_1 doi: 10.1093/ndt/15.7.953 – ident: e_1_3_2_19_1 doi: 10.1016/S0140-6736(87)90266-2 – volume: 22 start-page: 774 year: 2009 ident: e_1_3_2_24_1 article-title: Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease publication-title: J Nephrol contributor: fullname: Matsubara K – ident: e_1_3_2_3_1 doi: 10.1053/ajkd.1998.v32.pm9820470 – ident: e_1_3_2_8_1 doi: 10.1093/ndt/gfq273 – ident: e_1_3_2_2_1 doi: 10.1681/ASN.V1071606 – ident: e_1_3_2_27_1 doi: 10.4103/0971-4065.98758 – ident: e_1_3_2_17_1 doi: 10.1016/0003-2697(79)90738-3 – volume: 20 start-page: 471 year: 2007 ident: e_1_3_2_23_1 article-title: Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines publication-title: Int J Mol Med contributor: fullname: Malaponte G – ident: e_1_3_2_16_1 doi: 10.1093/clinchem/18.6.499 – volume: 2 start-page: 682 year: 2011 ident: e_1_3_2_30_1 article-title: Antioxidant enzymes status in South Indian haemodialysis patients publication-title: Int J Biol Med Res contributor: fullname: Reddy PE – ident: e_1_3_2_5_1 doi: 10.1093/ndt/17.suppl_8.33 – ident: e_1_3_2_15_1 doi: 10.1046/j.1523-1755.1999.00613.x – ident: e_1_3_2_7_1 doi: 10.1681/ASN.V13suppl_1s28 – ident: e_1_3_2_31_1 doi: 10.1515/CCLM.2002.019 – ident: e_1_3_2_22_1 doi: 10.2215/CJN.00870207 – ident: e_1_3_2_10_1 doi: 10.1016/j.tcm.2010.03.005 – volume: 2 start-page: 414 year: 2010 ident: e_1_3_2_28_1 article-title: Ferric reducing ability of plasma and lipid peroxidation in haemodialysis patients: intradialytic changes publication-title: Int J Nephrol Urol contributor: fullname: Reddy PE – ident: e_1_3_2_6_1 doi: 10.1053/j.ajkd.2009.06.022 – ident: e_1_3_2_18_1 doi: 10.1006/abio.1996.0292 – volume: 37 start-page: 91 year: 2008 ident: e_1_3_2_26_1 article-title: Effect of haemodialysis on oxidative stress in patients with chronic renal failure publication-title: J Fac Pharm Ankara contributor: fullname: Hacişevki A – ident: e_1_3_2_4_1 doi: 10.2215/CJN.03670807 – ident: e_1_3_2_20_1 doi: 10.1161/01.CIR.102.6.636 – ident: e_1_3_2_13_1 doi: 10.1093/ndt/gfl747 – ident: e_1_3_2_9_1 doi: 10.1093/ndt/gfl747 – ident: e_1_3_2_25_1 doi: 10.1074/jbc.272.52.32817 – ident: e_1_3_2_29_1 doi: 10.5812/ircmj.22045 – ident: e_1_3_2_21_1 doi: 10.1097/01.ASN.0000143744.72664.66 – ident: e_1_3_2_12_1 doi: 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6
SSID	ssj0015872
Score	2.3151197
Snippet	Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among... Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom it is 5-20... BACKGROUNDCardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among whom... Background : Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) among...
SourceID	doaj pubmedcentral proquest crossref pubmed informaworld
SourceType	Open Website Open Access Repository Aggregation Database Index Database Publisher
StartPage	534
SubjectTerms	Adult Aged Biomarkers - blood C-Reactive Protein - analysis Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - etiology Case-Control Studies Clinical Study End-stage renal disease Female Hemodialysis Humans Immune response India inflammation Inflammation - blood Kidney diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Male Malondialdehyde - blood Middle Aged Morbidity Oxidative Stress oxidative stress; Pentraxin-3 Pentraxins Population studies Renal Dialysis - adverse effects Risk Factors Serum Amyloid P-Component - analysis
SummonAdditionalLinks	– databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QFlfLaUiojcQ04iWM7Rx6teikXQNqb5ae6gs1Wza4EP4D_zYztrHYrpF56ipTESeyZiT97Zr4h5F0vQxSedZU1XFace1cZa8CubNdzy4RziTL_4pv8OldfzpAmZ1vqC2PCMj1wHrgPXrnWtIoJa6BxjNa5yDrLVeCqN31O82ViWkwV_0GnUtkmMCEMsW3mU-4OsmorLLvUzDGsS8GPQkmFc9POrJTI-29Rl_4PgN6Oo9yZmM4PyZOCKOnH3JOn5EEYjsijy-Izf0b-5gSCkS4GCmgPDhG0YJm869QMnq5-L3yi_6Y5cYQuMWTnZqQ5hZEaivsJvwK9CssV5pkgiQkdM6EHPrVws44UN3Wpy3S79OfCD-EPLR6g5-TH-dn3zxdVKb5QOYBE6yrASqtTESsmBCFr7wym4LLG2Sa0IE4AXqaT1nfRcWN8bQRIvTFtVAamRc7aF-RgWA3hFaEAMUVsRbBSIIG7sRwwCgaCwtKnN97NyPtp8PV15tjQ9URdWqSlUVq6SGtGPqGItjcjRXY6AYqji-LouxRnRvpdAet12iGJuZyJbu_4gJNJG3Sx-dSkZ4AJVDsjb7eXwVrRBWOGsNqMukFuIwDJDF7_MivPthfoQZZ1Da3lnlrtdXP_yrC4SozgAsvYd_L4PsblNXmMXc35lifkYH2zCW_Iw9FvTpON_QN4QCuP priority: 102 providerName: Directory of Open Access Journals
Title	Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease
URI	https://www.tandfonline.com/doi/abs/10.1080/0886022X.2018.1487857 https://www.ncbi.nlm.nih.gov/pubmed/30277113 https://www.proquest.com/docview/3109041383 https://search.proquest.com/docview/2115754008 https://pubmed.ncbi.nlm.nih.gov/PMC6171457 https://doaj.org/article/d8c3a3806ba94bffbccf05b48e489a98
Volume	40
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYHhAXxJtAqYzENdu8nDhHKK16KUICpL1ZftKIJqk2uxL8gP7vztjOqlshIXGKlMSJnZmJP3tmviHkQ9tYV5uMpUpWTVpVRqdSSbArxdpKZbXWnjL__FvzZcU_nyJNDptzYXzQvlbdcrjql0N36WMrr3t9PMeJHX-9OKmxajes5BdkAdhwXqJH1wHjvmITWA9G1xarOW0HCbU5VlwqVhjRxeEfwRvOsAof-u6aPC_35iZP4X-PwPRvMPR-NOWd6ensCXkccSX9GPr_lDywwzPy8CJ6zp-Tm5BGMNFuoID54OBAF3rvY6dyMHT83RlPAk5D-gjtMXBnPdGQyEglxV2FK0svbT9itglSmdAp0HrgUyND60Rxa5fqQLpLf3VmsH9o9AO9ID_OTr-fnKexBEOqARhtUgvrLcYd1k2wdZMbLTERNyu0KmwJQgX4JVmjDHO6ktLksgbZF7J0XMLkWGXlS3IwjIN9TSgAzdqVtVVNjTTuUlWAVDAcFBZArTQ6Icv544vrwLQh8pnANApOoOBEFFxCPqGIdjcjUbY_Ma5_iqguwnBdypJntZKge84prV3GVMVtBW9teULauwIWG79P4kJRE1H-owOHszaIaPm-SZsBMuBlQt7vLoPNoiNGDnbcTqJAhiOAyhm8_lVQnt0oZl1MSLOnVnvD3L8CZuJ5waNZvPnvlm_JIxxfSLU8JAeb9da-I4vJbI_8XsWRt7RbULorpA
link.rule.ids	230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider	National Library of Medicine
linkToHtml	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF3RIkFfuEMNBRaJV6eOr-tHKK2CaCokipS31V6pRW1XcSLBB_DfzOyuo6ZCQupTpGwcezVnvGd3Zs4Q8r6ujC11UsRS5FWc51rFQgrwK1nUuUxKpZxk_uxbdbZgn45RJqcYa2Fc0r6SzaS7bCddc-FyK69adTjmiR1-nR-V2LUbdvI75C74a5KMm_QQPCiY69kE_oP5teliLNxBSW2GPZfSBeZ0MXhLsIoV2IcPo3fVdJptrU5OxP-GhOm_iOjNfMprC9TJw1tO7RF5EBgp_eCHH5M7pntC7s1DzP0p-eMLEAbadBTYInxYQFHrovNUdJr2vxrt5MOpLzyhLab8LAfqSyCpoHgecWnohWl7rFNBERQ6eEEQ_Neg7TpQPBSmysv10p-N7sxvGiJIz8j3k-Pzo1kcmjfECijVKjawUyuYxY4LpqymWgks4U1SJVOTARyAuImikrqwKhdCT0UJqElFZpmAZTVPsudkt-s7s08oUNTSZqWRVYkC8ELmwHEwkRS2TrXQKiKT0Wj8ymt08OkofRoMztHgPBg8Ih_RtJsfo8S2-6Jf_uDBGlwzlQlAVykFoNZaqZRNCpkzk8NdaxaR-jow-MqdsFjfDoVn_3mAgxFFPLwz3CV1ApyCZRF5txkGb8cQjuhMvx54itpIQLITuP0LD7rNLEYMR6TaguPWNLdHAIVOUTyg7uWtr3xL7s_O56f89PPZl1dkD-fqCzYPyO5quTavyc6g12-cn_4FE29ANg
linkToPdf	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bahRBEG1MhOCL98to1BZ8nd25T8-jJlkimhBQYd-avprBzOyyswv6Af63Vd09SzYIgj4N7Ny2qVPTp7uqThHytqmNrXRSxlIUdVwUWsVCCvArWTaFTCqlnGT-6ef6fM6OT1AmZ9vqyyXtK9lO-qtu0reXLrdy2anpmCc2vTg7qrBrN6zkl9pO98ht8NkkGxfqIYBQMte3CXwIc2yz-Vi8g7LaDPsuZXPM62LwpWA1K7EXH0bw6jTNd2YoJ-R_Q8b0T2T0Zk7ltUlqdu8_hnef3A3MlL7zlzwgt0z_kBychdj7I_LLFyIMtO0psEY4WEBT56L0VPSaLn602smIU1-AQjtM_VkN1JdCUkFxX-LK0EvTLbBeBcVQ6OCFQfCpQeN1oLg5TJWX7aXfW92bnzREkh6Tr7OTL0encWjiECugVuvYwIqtZBY7L5iqTrUSWMqbZEpmJgdYAIETZS11aVUhhE5FBejJRG6ZgOm1SPInZL9f9OYZoUBVK5tXRtYVCsELWQDXwYRSWEI1QquITEbD8aXX6uDpKIEajM7R6DwYPSLv0bzbi1Fq2_2wWH3jwSJcM5ULQFglBaDXWqmUTUpZMFPAWxsWkeY6OPja7bRY3xaF53_5A4cjknj4drhbmgS4Bcsj8mZ7GrweQzmiN4vNwDPUSAKyncDrn3rgbUcx4jgi9Q4kd4a5ewaQ6JTFA_Ke__Odr8nBxfGMf_pw_vEFuYND9XWbh2R_vdqYl2Rv0JtXzlV_AxRyQrY
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+the+inflammatory+and+oxidative+stress+markers+during+a+single+hemodialysis+session+in+patients+with+chronic+kidney+disease&rft.jtitle=Renal+failure&rft.au=Sangeetha+Lakshmi%2C+B.&rft.au=Harini+Devi%2C+N.&rft.au=Suchitra%2C+M.+M.&rft.au=Srinivasa+Rao%2C+P.+V.+L.+N.&rft.date=2018-11-01&rft.pub=Taylor+%26+Francis&rft.issn=0886-022X&rft.eissn=1525-6049&rft.volume=40&rft.issue=1&rft.spage=534&rft.epage=540&rft_id=info:doi/10.1080%2F0886022X.2018.1487857&rft.externalDBID=0YH&rft.externalDocID=1487857
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0886-022X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0886-022X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0886-022X&client=summon